Reinaldo Rampolla
Medical Director of Lung Transplantation at Cedars-Sinai. Last author of a 2026 machine-learning study of baseline lung allograft dysfunction, a condition related to but not the same as CLAD.
As of . Primary source: ORCID record.
Summary
Reinaldo Rampolla is listed in the ORCID record as Medical Director of Lung Transplantation in the Division of Pulmonary Medicine at Cedars-Sinai Medical Center. Reinaldo Rampolla is included in this category because an opened abstract describes machine-learning models used to identify predictors of baseline lung allograft dysfunction. Among the papers read, only one uses machine learning, so this record describes a transplant clinician with machine-learning work rather than a methods specialist.
Work summary
Reinaldo Rampolla is the last author of a 2026 single-centre study of 124 adults who had bilateral lung transplants [DOI 10.1016/j.jhlto.2026.100553]. Machine-learning models (gradient boosting and classification trees) scored the importance of donor and recipient factors linked to baseline lung allograft dysfunction (BLAD, a form of early graft dysfunction that is related to, but not the same as, chronic lung allograft dysfunction), and the top factors were then tested with logistic regression. BLAD occurred in 58 of the 124 patients, and the abstract lists seven associated factors, including cold ischemia time, extremes of body mass index, intensive care stay and donor tobacco use. The other two papers read are not machine-learning studies: a multicentre analysis of donor-derived cell-free DNA, a blood marker of graft injury, in 103 single-lung recipients [DOI 10.1016/j.jhlto.2024.100155], and a study of donor oxygen levels and primary graft dysfunction in heart transplantation [DOI 10.1016/j.healun.2022.12.022].
Based on 3 or more opened abstracts. Written only from abstracts that were opened (PubMed or Europe PMC); full texts were not read. Plain-language explanations are added by the editors and are not from the papers.
Role and field
- Role
- Medical Director of Lung Transplantation, Cedars-Sinai Medical Center
- Role status
- verified, self-asserted in ORCID employment entry
- Role basis
- ORCID employment entry (current, no end date), read on 2026-10-10.
- Field
- pulmonary medicine; lung transplantation
- Field basis
- Division named in the ORCID employment entry: Medicine, Division of Pulmonary Medicine.
Only what a cited source supports is stated. Entries marked self-asserted come from the person's own ORCID record. The field is taken from the name of the unit, not inferred from the person's name.
Details
- affiliation
- Cedars-Sinai Medical Center (ORCID, self-asserted)
- ai evidence
- Abstract of 10.1016/j.jhlto.2026.100553 describes gradient boosting and classification tree models. The other two source papers do not use machine learning.
Sources and links
- ORCID record (primary)
- OpenAlex author profile
- Machine learning to identify predictors of baseline lung allograft dysfunction (JHLT Open 2026), DOI 10.1016/j.jhlto.2026.100553
- Donor-derived cell-free DNA after single lung transplantation (JHLT Open 2024), DOI 10.1016/j.jhlto.2024.100155
- Donor hyperoxia and cardiac primary graft dysfunction (Journal of Heart and Lung Transplantation 2023), DOI 10.1016/j.healun.2022.12.022
Known gaps in this record
- Baseline lung allograft dysfunction is related to, but not the same as, CLAD.
- Only one of the three source papers uses machine learning; the other two are included only to describe the wider work.
- The role is self-asserted in ORCID and may be out of date.
- Funding and conflicts of interest were not recorded.
- Full texts were not read.
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.